UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$237.77 USD
-11.79 (-4.72%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $237.50 -0.27 (-0.11%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
UNH 237.77 -11.79(-4.72%)
Will UNH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for UNH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UNH
Stock Market News for Jul 30, 2025
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
UNH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Trade Deficit Comes in Lower Than Expected
Pre-Markets Up Again on Big News Morning
Here's What Key Metrics Tell Us About UnitedHealth (UNH) Q2 Earnings
Other News for UNH
UnitedHealth: Everyone Is Overreacting
UnitedHealth Group: Buy This Falling Knife - Raised 2026 Premiums Trigger Recovery Prospects
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Bernstein Adjusts Price Target for UnitedHealth (UNH), Maintains Outperform Rating
UnitedHealth price target lowered by $40 at Bernstein, here's why